Ruzinurad
Ruzinurad (HR011303) is a highly selective URATl inhibitor (WO2020088641, compound I) . Ruzinurad can be used in the study of hyperuricemia[1].
Product Specifications
CAS Number
1638327-48-6
Product Name Alternative
HR011303; SHR4640
UNSPSC
12352005
Target
URAT1
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ruzinurad.html
Purity
99.26
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1(SC2=CC=NC3=CC=C(Br)C=C23)CCC1)O
Molecular Formula
C14H12BrNO2S
Molecular Weight
338.22
References & Citations
[1]WO2020088641
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942946-100 1x 100 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-D434674-2.5MG 2.5 mg
1-(2,6-Dichloro-4-hydroxphenyl)-1,3-dihydroindol-2-one-13C6
Sign In for Pricing
View Details 
LY401891 100 µg
Signal sequence receptor delta (SSR4) (NM_006280) Human Over-expression Lysate
Sign In for Pricing
View Details